Study reveals dumping syndrome risk in babies after esophageal repair

NCT ID NCT02525705

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 42 infants who had surgery for a rare birth defect called esophageal atresia type III. Researchers gave the babies a sugary drink to see how often they developed dumping syndrome, a condition causing rapid blood sugar changes. The goal was to find out how common this problem is at 3.5 months of age.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Oral glucose
What this could lead to
If successful, this study could help doctors better understand and monitor dumping syndrome in infants after esophageal surgery.
What could go wrong
This is a small, observational study with only 42 infants, so results may not apply to all cases. It measures frequency, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUMPING SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HP, Hôpital Necker

    Paris, France

  • CHU Grenoble

    Grenoble, France

  • CHU Nantes

    Nantes, France

  • CHU Rouen

    Rouen, France

  • CHU Strasbourg

    Strasbourg, France

  • CHU Toulouse, Hôpital Enfant

    Toulouse, France

  • Hôpital Edouard Herriot,Unité d'Hépatogastroentérologie et Nutrition Pédiatriques

    Lyon, France

  • Hôpital Jeanne de Flandre CHRU

    Lille, France

  • Hôpital Pellegrin - Hôpital d'Enfants,

    Bordeaux, France

  • Hôpital Robert Debré ,Service de chirurgie viscérale et urologique

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.